• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Axogen, Inc. - Common Stock (NQ:AXGN)

    40.95 +0.66 (+1.63%)
    Streaming Delayed Price Updated: 3:23 PM EDT, May 14, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 459,720
    Open 40.40
    Bid (Size) 40.93 (100)
    Ask (Size) 40.96 (200)
    Prev. Close 40.29
    Today's Range 39.52 - 41.13
    52wk Range 9.215 - 45.83
    Shares Outstanding 41,397,053
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    AxoGen Says Nerve Repair Strategy Intact as Reimbursement Wins Gather Steam ↗
    AxoGen (NASDAQ:AXGN) President and CEO Michael Dale said the company’s growth strategy remains centered on developing the market for peripheral nerve repair, while recent reimbursement wins are... 
    Via MarketBeat
    News headline image
    TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues
    From TELA Bio, Inc.
    Via GlobeNewswire

    Performance

    YTD
    +32.1%
    +32.1%
    1 Month
    +22.3%
    +22.3%
    3 Month
    +20.8%
    +20.8%
    6 Month
    +70.0%
    +70.0%
    1 Year
    +276.3%
    +276.3%

    More News

    Read More
    News headline image
    Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference
    From Axogen, Inc.
    Via GlobeNewswire
    News headline image
    Axogen (AXGN) Q3 2025 Earnings Transcript ↗
    Via The Motley Fool
    Axogen Inc (NASDAQ:AXGN) Rallies on Q1 Revenue Beat and Raised 2026 Guidance ↗
    Via Chartmill
    Axogen Inc (NASDAQ:AXGN) Reports Q4 2025 Revenue Growth but Misses Profit Estimates ↗
    Via Chartmill
    News headline image
    Axogen (AXGN) Q1 2025 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Axogen, Inc. Reports First Quarter 2026 Financial Results
    From Axogen, Inc.
    Via GlobeNewswire
    News headline image
    Capricorn Fund Makes a Huge Bet on Nerve Repair With 687,000 Share Axogen (AXGN) Investment Worth $22.4 Million ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    AXOGEN INC (NASDAQ:AXGN) Fits the Minervini Trend Template with Strong Growth Momentum ↗
    Via Chartmill
    News headline image
    Axogen (AXGN) Q2 2025 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Axogen, Inc. to Report First Quarter 2026 Financial Results on April 28, 2026
    From Axogen, Inc.
    Via GlobeNewswire
    News headline image
    Axogen Insider Sale of 5,221 Shares Follows 20% Revenue Growth in 2025. Here's What to Know ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This $6.5 Million Healthcare Trim Comes Amid a 71% Stock Surge and 20% Revenue Growth ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Axogen (AXGN) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    HighMark Wealth Management Buys 158,855 Shares of Axogen Stock ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Axogen, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results
    From Axogen, Inc.
    Via GlobeNewswire
    News headline image
    Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
    From Axogen, Inc.
    Via GlobeNewswire
    News headline image
    Axogen, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
    From Axogen, Inc.
    Via GlobeNewswire
    News headline image
    Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock
    From Axogen, Inc.
    Via GlobeNewswire
    News headline image
    Axogen Announces Proposed Public Offering of Common Stock
    From Axogen, Inc.
    Via GlobeNewswire
    News headline image
    Axogen CEO Axed 25,000 Shares From His Direct Holdings ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025
    From Axogen, Inc.
    Via GlobeNewswire
    News headline image
    Axogen, Inc. to Participate in the J.P. Morgan 2026 Healthcare Conference
    From Axogen, Inc.
    Via GlobeNewswire
    News headline image
    Gapping stocks in Thursday's session ↗
    Via Chartmill

    Frequently Asked Questions

    Is Axogen, Inc. - Common Stock publicly traded?
    Yes, Axogen, Inc. - Common Stock is publicly traded.
    What exchange does Axogen, Inc. - Common Stock trade on?
    Axogen, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Axogen, Inc. - Common Stock?
    The ticker symbol for Axogen, Inc. - Common Stock is AXGN on the Nasdaq Stock Market
    What is the current price of Axogen, Inc. - Common Stock?
    The current price of Axogen, Inc. - Common Stock is 40.95
    When was Axogen, Inc. - Common Stock last traded?
    The last trade of Axogen, Inc. - Common Stock was at 05/14/26 03:23 PM ET
    What is the market capitalization of Axogen, Inc. - Common Stock?
    The market capitalization of Axogen, Inc. - Common Stock is 1.70B
    How many shares of Axogen, Inc. - Common Stock are outstanding?
    Axogen, Inc. - Common Stock has 2B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.